SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors: Identification, Biobanking, and...

Area of Science:

• Immunology
• Virology
• Cellular Biology

Background:

• The ongoing SARS-CoV-2 pandemic necessitates effective treatments for hospitalized COVID-19 patients.
• Memory T cells, particularly CD45RA-negative subsets, are crucial for rapid and long-term immune responses against pathogens.
• Secondary infections are a significant concern in hospitalized COVID-19 patients.

Purpose of the Study:

• To determine the presence of SARS-CoV-2-specific T cells within CD45RA-negative memory T cells in convalescent donors.
• To evaluate the potential of these cells as an 'off-the-shelf' therapeutic option for COVID-19.

Main Methods:

• Analysis of blood samples from convalescent donors.
• Identification and characterization of SARS-CoV-2-specific memory T cells (CD3+, CD4+, CD8+) within CD45RA-negative subsets.
• Assessment of central memory and effector memory subpopulations.

Main Results:

• SARS-CoV-2-specific memory T cells were detected in all analyzed CD45RA-negative subsets (CD3+, CD4+, CD8+).
• These specific T cells were found in both central memory and effector memory subpopulations.
• The method for obtaining these cells is feasible, cost-effective, and requires minimal manipulation.

Conclusions:

• The study confirms the existence of SARS-CoV-2-specific memory T cells in convalescent individuals.
• These cells represent a promising, readily available 'off-the-shelf' therapeutic strategy for moderate to severe COVID-19.
• This approach could expand treatment options and help manage secondary infections in hospitalized patients.